Clinical trial
A Three Week Dose Escalation Study of PTHrP(1-36) in Postmenopausal Women
NCT00222872 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Three Week Dose Escalation Study of PTHrP(1-36) in Postmenopausal Women
- Lead sponsor
- University of Pittsburgh
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- September 30, 2008
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.